PMID- 30237786 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20191120 IS - 1664-2392 (Print) IS - 1664-2392 (Electronic) IS - 1664-2392 (Linking) VI - 9 DP - 2018 TI - Real Talk: The Inter-play Between the mTOR, AMPK, and Hexosamine Biosynthetic Pathways in Cell Signaling. PG - 522 LID - 10.3389/fendo.2018.00522 [doi] LID - 522 AB - O-linked N-acetylglucosamine, better known as O-GlcNAc, is a sugar post-translational modification participating in a diverse range of cell functions. Disruptions in the cycling of O-GlcNAc mediated by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), respectively, is a driving force for aberrant cell signaling in disease pathologies, such as diabetes, obesity, Alzheimer's disease, and cancer. Production of UDP-GlcNAc, the metabolic substrate for OGT, by the Hexosamine Biosynthetic Pathway (HBP) is controlled by the input of amino acids, fats, and nucleic acids, making O-GlcNAc a key nutrient-sensor for fluctuations in these macromolecules. The mammalian target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) pathways also participate in nutrient-sensing as a means of controlling cell activity and are significant factors in a variety of pathologies. Research into the individual nutrient-sensitivities of the HBP, AMPK, and mTOR pathways has revealed a complex regulatory dynamic, where their unique responses to macromolecule levels coordinate cell behavior. Importantly, cross-talk between these pathways fine-tunes the cellular response to nutrients. Strong evidence demonstrates that AMPK negatively regulates the mTOR pathway, but O-GlcNAcylation of AMPK lowers enzymatic activity and promotes growth. On the other hand, AMPK can phosphorylate OGT leading to changes in OGT function. Complex sets of interactions between the HBP, AMPK, and mTOR pathways integrate nutritional signals to respond to changes in the environment. In particular, examining these relationships using systems biology approaches might prove a useful method of exploring the complex nature of cell signaling. Overall, understanding the complex interactions of these nutrient pathways will provide novel mechanistic information into how nutrients influence health and disease. FAU - Cork, Gentry K AU - Cork GK AD - Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, United States. AD - Department of Pathology, University of Kansas Medical Center, Kansas City, KS, United States. FAU - Thompson, Jeffrey AU - Thompson J AD - Department of Biostatistics, University of Kansas Medical Center, Kansas City, KS, United States. FAU - Slawson, Chad AU - Slawson C AD - Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, United States. LA - eng GR - P30 GM122731/GM/NIGMS NIH HHS/United States GR - R01 DK100595/DK/NIDDK NIH HHS/United States GR - R03 CA223949/CA/NCI NIH HHS/United States PT - Journal Article PT - Review DEP - 20180906 PL - Switzerland TA - Front Endocrinol (Lausanne) JT - Frontiers in endocrinology JID - 101555782 PMC - PMC6136272 OTO - NOTNLM OT - AMPK 5' AMP-activated protein kinase OT - O-GlcNAc OT - OGA OT - OGT OT - mTOR (mammalian target of rapamycin) EDAT- 2018/09/22 06:00 MHDA- 2018/09/22 06:01 PMCR- 2018/01/01 CRDT- 2018/09/22 06:00 PHST- 2018/06/22 00:00 [received] PHST- 2018/08/21 00:00 [accepted] PHST- 2018/09/22 06:00 [entrez] PHST- 2018/09/22 06:00 [pubmed] PHST- 2018/09/22 06:01 [medline] PHST- 2018/01/01 00:00 [pmc-release] AID - 10.3389/fendo.2018.00522 [doi] PST - epublish SO - Front Endocrinol (Lausanne). 2018 Sep 6;9:522. doi: 10.3389/fendo.2018.00522. eCollection 2018.